[
  {
    "id": 342,
    "title": "Apple will appeal contempt ruling in Epic Games case over App Store",
    "date": "2025-05-05 21:29:00",
    "journal": "Reuters News",
    "company": "Americas",
    "region": "namz : North America | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.879570007324219,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 3,
    "sentence": "She refused to put her order on hold, accusing Apple of delaying and purposefully <span class=\"highlight-negative\">misleading</span> the court.",
    "sentenceRaw": "She refused to put her order on hold, accusing Apple of delaying and purposefully misleading the court.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 900,
    "title": "Apple shares rise after positive sales outlook signals iPhone recovery",
    "date": "2025-01-31 06:16:00",
    "journal": "Reuters News",
    "company": "APPLE-RESULTS",
    "region": "apacz : Asia Pacific | asiaz : Asia | china : China | chinaz : Greater China | devgcoz : Emerging Market Countries | dvpcoz : Developing Economies | easiaz : East Asia",
    "sentiment": "neutral",
    "sentimentScore": 0.61753648519516,
    "matchedText": "cautiously",
    "matchType": "word",
    "numMatches": 1,
    "sentence": "Apple has approached AI more <span class=\"highlight-negative\">cautiously</span> than many of its peers, eschewing the huge data center spending of rivals such as Microsoft and instead envisioning AI as features meant to help sell its latest hardware.",
    "sentenceRaw": "Apple has approached AI more cautiously than many of its peers, eschewing the huge data center spending of rivals such as Microsoft and instead envisioning AI as features meant to help sell its latest hardware.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 1805,
    "title": "Press Release AAPL Investors Have Opportunity to Lead Apple Inc. Securities Fraud Lawsuit",
    "date": "2025-08-05 03:17:00",
    "journal": "Dow Jones Newswires",
    "company": "N/A",
    "region": "namz : North America | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.905553936958313,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 4,
    "sentence": "Details of the case: According to the lawsuit, throughout the Class Period, defendants made false and <span class=\"highlight-negative\">misleading</span> statements and/or failed to disclose that: (1) Apple misstated the time it would take to integrate the advanced AI-based Siri features into its devices; (2) Accordingly, it was highly unlikely that these features would be available for the iPhone 16; (3) The lack of such advanced AI-based features would hurt iPhone 16 sales; (4) as a result, Apple&#x27;s business and/or financial prospects were overstated; and (5) as a result, Apple&#x27;s public statements were materially false and <span class=\"highlight-negative\">misleading</span> at all relevant times.",
    "sentenceRaw": "Details of the case: According to the lawsuit, throughout the Class Period, defendants made false and misleading statements and/or failed to disclose that: (1) Apple misstated the time it would take to integrate the advanced AI-based Siri features into its devices; (2) Accordingly, it was highly unlikely that these features would be available for the iPhone 16; (3) The lack of such advanced AI-based features would hurt iPhone 16 sales; (4) as a result, Apple's business and/or financial prospects were overstated; and (5) as a result, Apple's public statements were materially false and misleading at all relevant times.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 1806,
    "title": "Press Release AAPL Investors Have Opportunity to Lead Apple Inc. Securities Fraud Lawsuit",
    "date": "2025-08-05 03:17:00",
    "journal": "Dow Jones Newswires",
    "company": "N/A",
    "region": "namz : North America | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.905553936958313,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 4,
    "sentence": "Details of the case: According to the lawsuit, throughout the Class Period, defendants made false and <span class=\"highlight-negative\">misleading</span> statements and/or failed to disclose that: (1) Apple misstated the time it would take to integrate the advanced AI-based Siri features into its devices; (2) Accordingly, it was highly unlikely that these features would be available for the iPhone 16; (3) The lack of such advanced AI-based features would hurt iPhone 16 sales; (4) as a result, Apple&#x27;s business and/or financial prospects were overstated; and (5) as a result, Apple&#x27;s public statements were materially false and <span class=\"highlight-negative\">misleading</span> at all relevant times.",
    "sentenceRaw": "Details of the case: According to the lawsuit, throughout the Class Period, defendants made false and misleading statements and/or failed to disclose that: (1) Apple misstated the time it would take to integrate the advanced AI-based Siri features into its devices; (2) Accordingly, it was highly unlikely that these features would be available for the iPhone 16; (3) The lack of such advanced AI-based features would hurt iPhone 16 sales; (4) as a result, Apple's business and/or financial prospects were overstated; and (5) as a result, Apple's public statements were materially false and misleading at all relevant times.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 2782,
    "title": "Apple Intelligence Isn&#x27;t Very Smart Yet -- and Apple &#x27;s OK With That -- WSJ",
    "date": "2024-10-23 06:30:00",
    "journal": "Dow Jones Institutional News",
    "company": "N/A",
    "region": "namz : North America | usa : United States",
    "sentiment": "neutral",
    "sentimentScore": 0.712059617042542,
    "matchedText": "cautiously",
    "matchType": "word",
    "numMatches": 1,
    "sentence": "Yes, while other companies rush out generative-AI tools, sometimes with controversy, Apple is moving <span class=\"highlight-negative\">cautiously</span>.",
    "sentenceRaw": "Yes, while other companies rush out generative-AI tools, sometimes with controversy, Apple is moving cautiously.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 4791,
    "title": "Press Release Lawsuit Alert Investors who lost over $250,000 with shares of Apple Inc. (NASDAQ AAPL) should contact the Shareholders Foundation",
    "date": "2025-07-07 20:40:00",
    "journal": "Dow Jones Newswires",
    "company": "N/A",
    "region": "namz : North America | usa : United States | usca : California | usw : Western U.S.",
    "sentiment": "negative",
    "sentimentScore": 0.928389608860016,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 2,
    "sentence": "The plaintiff alleges that the defendants made false and/or <span class=\"highlight-negative\">misleading</span> statements and/or failed to disclose that Apple misstated the time it would take to integrate the advanced artificial intelligence (&quot;AI&quot;)-based Siri features into its devices, that accordingly, it was highly unlikely that these features would be available for the iPhone 16, that the lack of such advanced AI-based features would hurt iPhone 16 sales, and that as a result, Apple&#x27;s business and/or financial prospects were overstated.",
    "sentenceRaw": "The plaintiff alleges that the defendants made false and/or misleading statements and/or failed to disclose that Apple misstated the time it would take to integrate the advanced artificial intelligence (\"AI\")-based Siri features into its devices, that accordingly, it was highly unlikely that these features would be available for the iPhone 16, that the lack of such advanced AI-based features would hurt iPhone 16 sales, and that as a result, Apple's business and/or financial prospects were overstated.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 4855,
    "title": "Press Release AAPL CLASS ACTION FILED Kessler Topaz Meltzer &amp; Check, LLP Reminds Investors - a Securities Fraud Class Action Lawsuit Has Been Filed Against Apple Inc. (AAPL)",
    "date": "2025-07-14 21:32:00",
    "journal": "Dow Jones Newswires",
    "company": "N/A",
    "region": "namz : North America | usa : United States | usca : California | usw : Western U.S.",
    "sentiment": "negative",
    "sentimentScore": 0.917338669300079,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 5,
    "sentence": "DEFENDANTS&#x27; ALLEGED MISCONDUCT:  The complaint alleges that, throughout the Class Period, Defendants made false and <span class=\"highlight-negative\">misleading</span> statements and/or failed to disclose that: (1) Apple misstated the time it would take to integrate the advanced AI-based Siri features into its devices; (2) accordingly, it was highly unlikely that these features would be available for the iPhone 16; (3) the lack of such advanced AI-based features would hurt iPhone 16 sales; (4) as a result, Apple&#x27;s business and/or financial prospects were overstated; and (5) as a result of the foregoing, the company&#x27;s public statements were materially false and <span class=\"highlight-negative\">misleading</span> at all relevant times.",
    "sentenceRaw": "DEFENDANTS' ALLEGED MISCONDUCT:  The complaint alleges that, throughout the Class Period, Defendants made false and misleading statements and/or failed to disclose that: (1) Apple misstated the time it would take to integrate the advanced AI-based Siri features into its devices; (2) accordingly, it was highly unlikely that these features would be available for the iPhone 16; (3) the lack of such advanced AI-based features would hurt iPhone 16 sales; (4) as a result, Apple's business and/or financial prospects were overstated; and (5) as a result of the foregoing, the company's public statements were materially false and misleading at all relevant times.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 4856,
    "title": "Press Release AAPL CLASS ACTION FILED Kessler Topaz Meltzer &amp; Check, LLP Reminds Investors - a Securities Fraud Class Action Lawsuit Has Been Filed Against Apple Inc. (AAPL)",
    "date": "2025-07-14 21:32:00",
    "journal": "Dow Jones Newswires",
    "company": "N/A",
    "region": "namz : North America | usa : United States | usca : California | usw : Western U.S.",
    "sentiment": "negative",
    "sentimentScore": 0.917338669300079,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 5,
    "sentence": "DEFENDANTS&#x27; ALLEGED MISCONDUCT:  The complaint alleges that, throughout the Class Period, Defendants made false and <span class=\"highlight-negative\">misleading</span> statements and/or failed to disclose that: (1) Apple misstated the time it would take to integrate the advanced AI-based Siri features into its devices; (2) accordingly, it was highly unlikely that these features would be available for the iPhone 16; (3) the lack of such advanced AI-based features would hurt iPhone 16 sales; (4) as a result, Apple&#x27;s business and/or financial prospects were overstated; and (5) as a result of the foregoing, the company&#x27;s public statements were materially false and <span class=\"highlight-negative\">misleading</span> at all relevant times.",
    "sentenceRaw": "DEFENDANTS' ALLEGED MISCONDUCT:  The complaint alleges that, throughout the Class Period, Defendants made false and misleading statements and/or failed to disclose that: (1) Apple misstated the time it would take to integrate the advanced AI-based Siri features into its devices; (2) accordingly, it was highly unlikely that these features would be available for the iPhone 16; (3) the lack of such advanced AI-based features would hurt iPhone 16 sales; (4) as a result, Apple's business and/or financial prospects were overstated; and (5) as a result of the foregoing, the company's public statements were materially false and misleading at all relevant times.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 5895,
    "title": "GLOBAL MARKETS-Stocks tick up as Apple climbs, tariffs in focus",
    "date": "2025-01-31 20:23:00",
    "journal": "Reuters News",
    "company": "All Retail",
    "region": "namz : North America | usa : United States",
    "sentiment": "positive",
    "sentimentScore": 0.951754152774811,
    "matchedText": "cautiously",
    "matchType": "word",
    "numMatches": 3,
    "sentence": "Apple added to the <span class=\"highlight-negative\">cautiously</span> optimistic mood late on Thursday when it forecast relatively strong sales growth, pushing its stock up 4.2% in early Friday trading.",
    "sentenceRaw": "Apple added to the cautiously optimistic mood late on Thursday when it forecast relatively strong sales growth, pushing its stock up 4.2% in early Friday trading.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 5909,
    "title": "GLOBAL MARKETS-Stocks tick up as Apple climbs, tariffs in focus",
    "date": "2025-01-31 21:22:00",
    "journal": "Reuters News",
    "company": "All Retail",
    "region": "namz : North America | usa : United States",
    "sentiment": "positive",
    "sentimentScore": 0.951759219169617,
    "matchedText": "cautiously",
    "matchType": "word",
    "numMatches": 3,
    "sentence": "Apple added to the <span class=\"highlight-negative\">cautiously</span> optimistic mood late on Thursday when it forecast relatively strong sales growth, pushing its stock up 1.4% in early Friday trading.",
    "sentenceRaw": "Apple added to the cautiously optimistic mood late on Thursday when it forecast relatively strong sales growth, pushing its stock up 1.4% in early Friday trading.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 5926,
    "title": "GLOBAL MARKETS-Stocks led higher by Apple , dollar muted as tariffs loom",
    "date": "2025-01-31 22:42:00",
    "journal": "Reuters News",
    "company": "Commodities Markets",
    "region": "namz : North America | usa : United States",
    "sentiment": "positive",
    "sentimentScore": 0.95085334777832,
    "matchedText": "cautiously",
    "matchType": "word",
    "numMatches": 3,
    "sentence": "Apple added to the <span class=\"highlight-negative\">cautiously</span> optimistic mood late on Thursday when it forecast relatively strong sales growth, pushing its stock up about 0.5% in Friday trading.",
    "sentenceRaw": "Apple added to the cautiously optimistic mood late on Thursday when it forecast relatively strong sales growth, pushing its stock up about 0.5% in Friday trading.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 7587,
    "title": "Apple sued over &#x27;carbon neutral&#x27; claim for watches",
    "date": "2025-02-27 20:56:00",
    "journal": "Reuters News",
    "company": "All Retail",
    "region": "namz : North America | usa : United States | usca : California | usw : Western U.S.",
    "sentiment": "negative",
    "sentimentScore": 0.950134038925171,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 3,
    "sentence": "Feb 27 (Reuters) - Apple has been sued by consumers who said its claim that three versions of Apple Watches are &quot;carbon neutral&quot; and environmentally friendly is false and <span class=\"highlight-negative\">misleading</span>.",
    "sentenceRaw": "Feb 27 (Reuters) - Apple has been sued by consumers who said its claim that three versions of Apple Watches are \"carbon neutral\" and environmentally friendly is false and misleading.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 7593,
    "title": "Apple sued over &#x27;carbon neutral&#x27; claim for watches",
    "date": "2025-02-27 20:56:00",
    "journal": "Reuters News",
    "company": "All Retail",
    "region": "namz : North America | usa : United States | usca : California | usw : Western U.S.",
    "sentiment": "neutral",
    "sentimentScore": 0.490077972412109,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 1,
    "sentence": "&quot;Because Apple&#x27;s carbon neutrality claims are predicated on the efficacy and legitimacy of these projects, Apple’s carbon neutrality claims are false and <span class=\"highlight-negative\">misleading</span>.&quot;",
    "sentenceRaw": "\"Because Apple's carbon neutrality claims are predicated on the efficacy and legitimacy of these projects, Apple’s carbon neutrality claims are false and misleading.\"",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 7604,
    "title": "Apple sued over &#x27;carbon neutral&#x27; claim for watches",
    "date": "2025-02-28 00:37:00",
    "journal": "Reuters News",
    "company": "APPLE",
    "region": "namz : North America | usa : United States | usca : California | usw : Western U.S.",
    "sentiment": "negative",
    "sentimentScore": 0.94622403383255,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 3,
    "sentence": "(Reuters) - Apple has been sued by consumers who said its claim that three versions of Apple Watches are &quot;carbon neutral&quot; and environmentally friendly is false and <span class=\"highlight-negative\">misleading</span>.",
    "sentenceRaw": "(Reuters) - Apple has been sued by consumers who said its claim that three versions of Apple Watches are \"carbon neutral\" and environmentally friendly is false and misleading.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 7609,
    "title": "UPDATE 1- Apple sued over &#x27;carbon neutral&#x27; claim for watches",
    "date": "2025-02-28 00:36:00",
    "journal": "Reuters News",
    "company": "All Retail",
    "region": "namz : North America | usa : United States | usca : California | usw : Western U.S.",
    "sentiment": "negative",
    "sentimentScore": 0.949572503566742,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 3,
    "sentence": "(Adds Apple comment, paragraphs 8-9)  By Jonathan Stempel  Feb 27 (Reuters) - Apple has been sued by consumers who said its claim that three versions of Apple Watches are &quot;carbon neutral&quot; and environmentally friendly is false and <span class=\"highlight-negative\">misleading</span>.",
    "sentenceRaw": "(Adds Apple comment, paragraphs 8-9)  By Jonathan Stempel  Feb 27 (Reuters) - Apple has been sued by consumers who said its claim that three versions of Apple Watches are \"carbon neutral\" and environmentally friendly is false and misleading.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 14523,
    "title": "Boeing files unfair labor practice charge against striking union",
    "date": "2024-10-11 09:13:00",
    "journal": "Reuters News",
    "company": "BOEING-LABOR-USA",
    "region": "namz : North America | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.961435437202454,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 4,
    "sentence": "Boeing said the union had engaged in a &quot;pattern of bad faith bargaining&quot; and its &quot;public narrative is <span class=\"highlight-negative\">misleading</span> and making it difficult to find a solution for our employees.&quot;",
    "sentenceRaw": "Boeing said the union had engaged in a \"pattern of bad faith bargaining\" and its \"public narrative is misleading and making it difficult to find a solution for our employees.\"",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 16342,
    "title": "US judge orders Boeing , DOJ to detail diversity policy before deciding on plea",
    "date": "2024-10-16 04:13:00",
    "journal": "Reuters News",
    "company": "Aerospace / Defense (Legacy)",
    "region": "apacz : Asia Pacific | asiaz : Asia | devgcoz : Emerging Market Countries | dvpcoz : Developing Economies | indon : Indonesia | namz : North America | seasiaz : Southeast Asia | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.873744964599609,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 4,
    "sentence": "The order is the latest hurdle Boeing faces to avoid a potentially embarrassing trial and plead guilty to <span class=\"highlight-negative\">misleading</span> the Federal Aviation Administration and violating a 2021 deferred prosecution agreement.",
    "sentenceRaw": "The order is the latest hurdle Boeing faces to avoid a potentially embarrassing trial and plead guilty to misleading the Federal Aviation Administration and violating a 2021 deferred prosecution agreement.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 17608,
    "title": "Boeing re-captures Turkish airline Pegasus with MAX jet order",
    "date": "2024-12-20 13:36:00",
    "journal": "Reuters News",
    "company": "BOEING",
    "region": "No",
    "sentiment": "negative",
    "sentimentScore": 0.841559231281281,
    "matchedText": "cautiously",
    "matchType": "word",
    "numMatches": 1,
    "sentence": "With the strike over, Boeing <span class=\"highlight-negative\">cautiously</span> restarted 737 production in early December, Reuters first reported.",
    "sentenceRaw": "With the strike over, Boeing cautiously restarted 737 production in early December, Reuters first reported.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 17788,
    "title": "Aerospace analysts are guardedly hopeful about Boeing &#x27;s path forward",
    "date": "2025-01-30 04:55:00",
    "journal": "Reuters News",
    "company": "Aerospace / Defense (Legacy)",
    "region": "No",
    "sentiment": "negative",
    "sentimentScore": 0.562609314918518,
    "matchedText": "cautiously",
    "matchType": "word",
    "numMatches": 4,
    "sentence": "* Analysts are <span class=\"highlight-negative\">cautiously</span> optimistic about Boeing CEO&#x27;s promises to increase production * Boeing&#x27;s past leadership failures are a shadow over current CEO * Airlines want more jets, suppliers want more business, but everyone is cautious By Dan Catchpole SEATTLE, Jan 29 - CEO Kelly Ortberg took over at Boeing knowing that the company was in trouble.",
    "sentenceRaw": "* Analysts are cautiously optimistic about Boeing CEO's promises to increase production * Boeing's past leadership failures are a shadow over current CEO * Airlines want more jets, suppliers want more business, but everyone is cautious By Dan Catchpole SEATTLE, Jan 29 - CEO Kelly Ortberg took over at Boeing knowing that the company was in trouble.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 21273,
    "title": "Boeing must face shareholder class action following MAX 9 blowout",
    "date": "2025-03-08 05:53:00",
    "journal": "Reuters News",
    "company": "Aerospace & Defense (TRBC level 4)",
    "region": "namz : North America | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.957826793193817,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 2,
    "sentence": "Boeing shareholders said the company&#x27;s <span class=\"highlight-negative\">misleading</span> statements inflated its stock price after two MAX planes crashed in October 2018 and March 2019, killing 346.",
    "sentenceRaw": "Boeing shareholders said the company's misleading statements inflated its stock price after two MAX planes crashed in October 2018 and March 2019, killing 346.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 21820,
    "title": "Boeing posts smaller loss as jet deliveries rise",
    "date": "2025-07-29 17:02:00",
    "journal": "Reuters News",
    "company": "Aerospace & Defense (TRBC level 4)",
    "region": "namz : North America | usa : United States",
    "sentiment": "positive",
    "sentimentScore": 0.940459668636322,
    "matchedText": "cautiously",
    "matchType": "word",
    "numMatches": 3,
    "sentence": "After years of grappling with quality issues and production delays on its flagship 737 MAX, Boeing has <span class=\"highlight-negative\">cautiously</span> ramped up monthly output this year.",
    "sentenceRaw": "After years of grappling with quality issues and production delays on its flagship 737 MAX, Boeing has cautiously ramped up monthly output this year.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 23743,
    "title": "Boeing Stock Slips Despite Deal With Trump&#x27;s Justice Department. -- Barrons.com",
    "date": "2025-05-27 23:31:00",
    "journal": "Dow Jones Newswires",
    "company": "N/A",
    "region": "namz : North America | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.471816718578339,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 3,
    "sentence": "In 2021, Boeing agreed to a deferred prosecution agreement to settle charges that the company committed fraud by <span class=\"highlight-negative\">misleading</span> government regulators about its flight-control software.",
    "sentenceRaw": "In 2021, Boeing agreed to a deferred prosecution agreement to settle charges that the company committed fraud by misleading government regulators about its flight-control software.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 23809,
    "title": "Boeing tackles US-China trade threat, shares rise on smaller-than-expected loss",
    "date": "2025-04-23 22:12:00",
    "journal": "Reuters News",
    "company": "Aerospace & Defense (TRBC level 4)",
    "region": "apacz : Asia Pacific | asiaz : Asia | china : China | chinaz : Greater China | devgcoz : Emerging Market Countries | dvpcoz : Developing Economies | easiaz : East Asia | namz : North America | usa : United States",
    "sentiment": "positive",
    "sentimentScore": 0.938770890235901,
    "matchedText": "cautiously",
    "matchType": "word",
    "numMatches": 1,
    "sentence": "Ortberg, who took the planemaker&#x27;s helm last year promising to <span class=\"highlight-negative\">cautiously</span> grow output, told analysts Boeing is producing 737s at a monthly rate in the low 30s and expects to get to the 38 per month cap over the next few months.",
    "sentenceRaw": "Ortberg, who took the planemaker's helm last year promising to cautiously grow output, told analysts Boeing is producing 737s at a monthly rate in the low 30s and expects to get to the 38 per month cap over the next few months.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 24110,
    "title": "EMIRATES AIRLINE PRESIDENT SAYS BOEING MANAGEMENT IS CAUTIOUSLY OPTIMISTIC OVER ITS RECOVERY",
    "date": "2025-06-01 13:23:00",
    "journal": "Reuters News",
    "company": "Aerospace / Defense (Legacy)",
    "region": "No",
    "sentiment": "positive",
    "sentimentScore": 0.925204277038574,
    "matchedText": "cautiously",
    "matchType": "word",
    "numMatches": 2,
    "sentence": "EMIRATES AIRLINE PRESIDENT SAYS BOEING MANAGEMENT IS <span class=\"highlight-negative\">cautiously</span> OPTIMISTIC OVER ITS RECOVERY",
    "sentenceRaw": "EMIRATES AIRLINE PRESIDENT SAYS BOEING MANAGEMENT IS CAUTIOUSLY OPTIMISTIC OVER ITS RECOVERY",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 24319,
    "title": "Boeing &#x27;s quarterly loss shrinks as jet deliveries rebound, but shares drop",
    "date": "2025-07-30 04:12:00",
    "journal": "Reuters News",
    "company": "Aerospace / Defense (Legacy)",
    "region": "namz : North America | usa : United States",
    "sentiment": "positive",
    "sentimentScore": 0.933600604534149,
    "matchedText": "cautiously",
    "matchType": "word",
    "numMatches": 2,
    "sentence": "The results highlighted Boeing&#x27;s efforts to <span class=\"highlight-negative\">cautiously</span> increase monthly output this year, following years of quality issues and production delays on its flagship 737 MAX.",
    "sentenceRaw": "The results highlighted Boeing's efforts to cautiously increase monthly output this year, following years of quality issues and production delays on its flagship 737 MAX.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 24734,
    "title": "ANALYSIS-CEO pulled Boeing out of nosedive, but new challenges approach",
    "date": "2025-08-08 15:30:00",
    "journal": "Reuters News",
    "company": "Aerospace & Defense (NEC) (TRBC level 5)",
    "region": "namz : North America | seattl : Seattle | usa : United States | usw : Western U.S. | uswa : Washington State",
    "sentiment": "negative",
    "sentimentScore": 0.62806499004364,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 2,
    "sentence": "When Ortberg arrived, Boeing - once celebrated for helping win World War Two and landing men on the moon - had become synonymous with cutting corners, prioritizing profits over production quality, and <span class=\"highlight-negative\">misleading</span> regulators and customers.",
    "sentenceRaw": "When Ortberg arrived, Boeing - once celebrated for helping win World War Two and landing men on the moon - had become synonymous with cutting corners, prioritizing profits over production quality, and misleading regulators and customers.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 27070,
    "title": "Intel beats shareholder lawsuit over $32 billion stock plunge",
    "date": "2025-07-24 21:06:00",
    "journal": "Reuters News",
    "company": "Company News",
    "region": "namz : North America | usa : United States | usca : California | usw : Western U.S.",
    "sentiment": "negative",
    "sentimentScore": 0.821768641471863,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 1,
    "sentence": "In a 21-page decision, Thompson said Intel made clear that foundry results would be &quot;obscured&quot; until 2024, meaning its earlier financial reporting was not false and <span class=\"highlight-negative\">misleading</span>.",
    "sentenceRaw": "In a 21-page decision, Thompson said Intel made clear that foundry results would be \"obscured\" until 2024, meaning its earlier financial reporting was not false and misleading.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 31826,
    "title": "Intel defeats shareholder lawsuit over foundry losses, $32 billion plunge",
    "date": "2025-03-05 22:29:00",
    "journal": "Reuters News",
    "company": "Advanced Micro Devices Inc",
    "region": "namz : North America | usa : United States | usca : California | usw : Western U.S.",
    "sentiment": "negative",
    "sentimentScore": 0.950411796569824,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 3,
    "sentence": "Thompson also said statements last March by former Chief Executive Patrick Gelsinger that Intel was enjoying &quot;significant traction&quot; and &quot;growing demand for our foundry offering&quot; were not <span class=\"highlight-negative\">misleading</span> because they concerned specific customers rather than overall revenue, which was falling.",
    "sentenceRaw": "Thompson also said statements last March by former Chief Executive Patrick Gelsinger that Intel was enjoying \"significant traction\" and \"growing demand for our foundry offering\" were not misleading because they concerned specific customers rather than overall revenue, which was falling.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 37952,
    "title": "Press Release Investors in Walgreens Boots Alliance , Inc. Should Contact The Gross Law Firm Before March 31, 2025 to Discuss Your Rights - WBA",
    "date": "2025-03-24 15:15:00",
    "journal": "Dow Jones Institutional News",
    "company": "N/A",
    "region": "namz : North America | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.798597753047943,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 11,
    "sentence": "id=137683&amp;from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or <span class=\"highlight-negative\">misleading</span> statements and/or failed to disclose that: (i) contrary to the Company&#x27;s purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens&#x27; revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company&#x27;s public statements were materially false and <span class=\"highlight-negative\">misleading</span> at all relevant times.",
    "sentenceRaw": "id=137683&from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) contrary to the Company's purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens' revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 37953,
    "title": "Press Release Investors in Walgreens Boots Alliance , Inc. Should Contact The Gross Law Firm Before March 31, 2025 to Discuss Your Rights - WBA",
    "date": "2025-03-24 15:15:00",
    "journal": "Dow Jones Institutional News",
    "company": "N/A",
    "region": "namz : North America | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.798597753047943,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 11,
    "sentence": "id=137683&amp;from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or <span class=\"highlight-negative\">misleading</span> statements and/or failed to disclose that: (i) contrary to the Company&#x27;s purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens&#x27; revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company&#x27;s public statements were materially false and <span class=\"highlight-negative\">misleading</span> at all relevant times.",
    "sentenceRaw": "id=137683&from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) contrary to the Company's purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens' revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 37975,
    "title": "Press Release Shareholders that lost money on Walgreens Boots Alliance , Inc.(WBA) Urged to Join Class Action - Contact The Gross Law Firm to Learn More",
    "date": "2025-03-27 15:15:00",
    "journal": "Dow Jones Institutional News",
    "company": "N/A",
    "region": "namz : North America | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.808894515037537,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 11,
    "sentence": "id=138810&amp;from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or <span class=\"highlight-negative\">misleading</span> statements and/or failed to disclose that: (i) contrary to the Company&#x27;s purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens&#x27; revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company&#x27;s public statements were materially false and <span class=\"highlight-negative\">misleading</span> at all relevant times.",
    "sentenceRaw": "id=138810&from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) contrary to the Company's purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens' revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 37976,
    "title": "Press Release Shareholders that lost money on Walgreens Boots Alliance , Inc.(WBA) Urged to Join Class Action - Contact The Gross Law Firm to Learn More",
    "date": "2025-03-27 15:15:00",
    "journal": "Dow Jones Institutional News",
    "company": "N/A",
    "region": "namz : North America | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.808894515037537,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 11,
    "sentence": "id=138810&amp;from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or <span class=\"highlight-negative\">misleading</span> statements and/or failed to disclose that: (i) contrary to the Company&#x27;s purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens&#x27; revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company&#x27;s public statements were materially false and <span class=\"highlight-negative\">misleading</span> at all relevant times.",
    "sentenceRaw": "id=138810&from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) contrary to the Company's purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens' revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 37998,
    "title": "Press Release WBA Deadline WBA Investors Have Opportunity to Lead Walgreens Boots Alliance , Inc. Securities Fraud Lawsuit",
    "date": "2025-03-27 23:42:00",
    "journal": "Dow Jones Institutional News",
    "company": "N/A",
    "region": "namz : North America | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.832338273525238,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 8,
    "sentence": "Details of the case: According to the lawsuit, defendants, throughout the Class Period, failed to disclose to investors that: (1) contrary to Walgreens&#x27; purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement of the same; (2) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (3) Walgreens&#x27; revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (4) as a result, Walgreens&#x27; public statements were materially false and <span class=\"highlight-negative\">misleading</span> at all relevant times.",
    "sentenceRaw": "Details of the case: According to the lawsuit, defendants, throughout the Class Period, failed to disclose to investors that: (1) contrary to Walgreens' purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement of the same; (2) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (3) Walgreens' revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (4) as a result, Walgreens' public statements were materially false and misleading at all relevant times.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 38284,
    "title": "Press Release Walgreens Boots Alliance , Inc. Class Action The Gross Law Firm Reminds Walgreens Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 31, 2025 - WBA",
    "date": "2025-03-31 15:15:00",
    "journal": "Dow Jones Institutional News",
    "company": "N/A",
    "region": "namz : North America | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.808016061782837,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 11,
    "sentence": "id=139392&amp;from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or <span class=\"highlight-negative\">misleading</span> statements and/or failed to disclose that: (i) contrary to the Company&#x27;s purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens&#x27; revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company&#x27;s public statements were materially false and <span class=\"highlight-negative\">misleading</span> at all relevant times.",
    "sentenceRaw": "id=139392&from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) contrary to the Company's purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens' revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 38285,
    "title": "Press Release Walgreens Boots Alliance , Inc. Class Action The Gross Law Firm Reminds Walgreens Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 31, 2025 - WBA",
    "date": "2025-03-31 15:15:00",
    "journal": "Dow Jones Institutional News",
    "company": "N/A",
    "region": "namz : North America | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.808016061782837,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 11,
    "sentence": "id=139392&amp;from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or <span class=\"highlight-negative\">misleading</span> statements and/or failed to disclose that: (i) contrary to the Company&#x27;s purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens&#x27; revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company&#x27;s public statements were materially false and <span class=\"highlight-negative\">misleading</span> at all relevant times.",
    "sentenceRaw": "id=139392&from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) contrary to the Company's purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens' revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 38360,
    "title": "Press Release Shareholders that lost money on Walgreens Boots Alliance , Inc.(WBA) should contact The Gross Law Firm about pending Class Action - WBA",
    "date": "2025-03-10 15:15:00",
    "journal": "Dow Jones Institutional News",
    "company": "N/A",
    "region": "namz : North America | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.807712733745575,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 11,
    "sentence": "id=134595&amp;from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or <span class=\"highlight-negative\">misleading</span> statements and/or failed to disclose that: (i) contrary to the Company&#x27;s purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens&#x27; revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company&#x27;s public statements were materially false and <span class=\"highlight-negative\">misleading</span> at all relevant times.",
    "sentenceRaw": "id=134595&from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) contrary to the Company's purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens' revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 38361,
    "title": "Press Release Shareholders that lost money on Walgreens Boots Alliance , Inc.(WBA) should contact The Gross Law Firm about pending Class Action - WBA",
    "date": "2025-03-10 15:15:00",
    "journal": "Dow Jones Institutional News",
    "company": "N/A",
    "region": "namz : North America | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.807712733745575,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 11,
    "sentence": "id=134595&amp;from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or <span class=\"highlight-negative\">misleading</span> statements and/or failed to disclose that: (i) contrary to the Company&#x27;s purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens&#x27; revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company&#x27;s public statements were materially false and <span class=\"highlight-negative\">misleading</span> at all relevant times.",
    "sentenceRaw": "id=134595&from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) contrary to the Company's purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens' revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 38390,
    "title": "Press Release WBA Deadline Walgreens Boots Alliance , Inc. Sued for Securities Law Violations - Contact The Rosen Law Firm Before September 10, 2024 to Discuss Your Rights - WBA",
    "date": "2024-09-08 22:45:00",
    "journal": "Dow Jones Institutional News",
    "company": "N/A",
    "region": "namz : North America | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.833873808383942,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 5,
    "sentence": "Details of the Case: According to the lawsuit, throughout the Class Period, defendants provided overwhelmingly positive statements to investors about Walgreens&#x27; expected revenue for the 2024 fiscal year while, at the same time, disseminating materially false and <span class=\"highlight-negative\">misleading</span> statements and/or concealing material adverse facts concerning the true state of Walgreens&#x27; pharmacy division; notably, that it was not truly equipped to handle the ongoing challenges in its industry and that Walgreens would require significant restructuring to create a sustainable model.",
    "sentenceRaw": "Details of the Case: According to the lawsuit, throughout the Class Period, defendants provided overwhelmingly positive statements to investors about Walgreens' expected revenue for the 2024 fiscal year while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Walgreens' pharmacy division; notably, that it was not truly equipped to handle the ongoing challenges in its industry and that Walgreens would require significant restructuring to create a sustainable model.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 38481,
    "title": "Press Release Shareholders of Walgreens Boots Alliance , Inc. Should Contact The Gross Law Firm Before March 31, 2025 to Discuss Your Rights - WBA",
    "date": "2025-02-13 16:15:00",
    "journal": "Dow Jones Institutional News",
    "company": "N/A",
    "region": "namz : North America | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.810171961784363,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 11,
    "sentence": "id=128954&amp;from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or <span class=\"highlight-negative\">misleading</span> statements and/or failed to disclose that: (i) contrary to the Company&#x27;s purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens&#x27; revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company&#x27;s public statements were materially false and <span class=\"highlight-negative\">misleading</span> at all relevant times.",
    "sentenceRaw": "id=128954&from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) contrary to the Company's purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens' revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 38482,
    "title": "Press Release Shareholders of Walgreens Boots Alliance , Inc. Should Contact The Gross Law Firm Before March 31, 2025 to Discuss Your Rights - WBA",
    "date": "2025-02-13 16:15:00",
    "journal": "Dow Jones Institutional News",
    "company": "N/A",
    "region": "namz : North America | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.810171961784363,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 11,
    "sentence": "id=128954&amp;from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or <span class=\"highlight-negative\">misleading</span> statements and/or failed to disclose that: (i) contrary to the Company&#x27;s purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens&#x27; revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company&#x27;s public statements were materially false and <span class=\"highlight-negative\">misleading</span> at all relevant times.",
    "sentenceRaw": "id=128954&from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) contrary to the Company's purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens' revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 38581,
    "title": "Press Release The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 31, 2025 in Walgreens Boots Alliance , Inc. Lawsuit - WBA",
    "date": "2025-03-03 16:15:00",
    "journal": "Dow Jones Institutional News",
    "company": "N/A",
    "region": "namz : North America | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.810114979743958,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 11,
    "sentence": "id=132965&amp;from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or <span class=\"highlight-negative\">misleading</span> statements and/or failed to disclose that: (i) contrary to the Company&#x27;s purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens&#x27; revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company&#x27;s public statements were materially false and <span class=\"highlight-negative\">misleading</span> at all relevant times.",
    "sentenceRaw": "id=132965&from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) contrary to the Company's purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens' revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 38582,
    "title": "Press Release The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 31, 2025 in Walgreens Boots Alliance , Inc. Lawsuit - WBA",
    "date": "2025-03-03 16:15:00",
    "journal": "Dow Jones Institutional News",
    "company": "N/A",
    "region": "namz : North America | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.810114979743958,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 11,
    "sentence": "id=132965&amp;from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or <span class=\"highlight-negative\">misleading</span> statements and/or failed to disclose that: (i) contrary to the Company&#x27;s purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens&#x27; revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company&#x27;s public statements were materially false and <span class=\"highlight-negative\">misleading</span> at all relevant times.",
    "sentenceRaw": "id=132965&from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) contrary to the Company's purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens' revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 38632,
    "title": "Press Release WBA LAWSUIT ALERT The Gross Law Firm Notifies Walgreens Boots Alliance , Inc. Investors of a Class Action Lawsuit and Upcoming Deadline",
    "date": "2025-02-06 16:15:00",
    "journal": "Dow Jones Institutional News",
    "company": "N/A",
    "region": "namz : North America | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.808945119380951,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 11,
    "sentence": "id=127285&amp;from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or <span class=\"highlight-negative\">misleading</span> statements and/or failed to disclose that: (i) contrary to the Company&#x27;s purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens&#x27; revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company&#x27;s public statements were materially false and <span class=\"highlight-negative\">misleading</span> at all relevant times.",
    "sentenceRaw": "id=127285&from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) contrary to the Company's purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens' revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 38633,
    "title": "Press Release WBA LAWSUIT ALERT The Gross Law Firm Notifies Walgreens Boots Alliance , Inc. Investors of a Class Action Lawsuit and Upcoming Deadline",
    "date": "2025-02-06 16:15:00",
    "journal": "Dow Jones Institutional News",
    "company": "N/A",
    "region": "namz : North America | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.808945119380951,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 11,
    "sentence": "id=127285&amp;from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or <span class=\"highlight-negative\">misleading</span> statements and/or failed to disclose that: (i) contrary to the Company&#x27;s purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens&#x27; revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company&#x27;s public statements were materially false and <span class=\"highlight-negative\">misleading</span> at all relevant times.",
    "sentenceRaw": "id=127285&from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) contrary to the Company's purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens' revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 38677,
    "title": "Press Release Investors in Walgreens Boots Alliance , Inc. Should Contact The Gross Law Firm Before March 31, 2025 to Discuss Your Rights - WBA",
    "date": "2025-02-10 16:15:00",
    "journal": "Dow Jones Institutional News",
    "company": "N/A",
    "region": "namz : North America | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.809358179569244,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 11,
    "sentence": "id=127859&amp;from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or <span class=\"highlight-negative\">misleading</span> statements and/or failed to disclose that: (i) contrary to the Company&#x27;s purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens&#x27; revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company&#x27;s public statements were materially false and <span class=\"highlight-negative\">misleading</span> at all relevant times.",
    "sentenceRaw": "id=127859&from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) contrary to the Company's purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens' revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 38678,
    "title": "Press Release Investors in Walgreens Boots Alliance , Inc. Should Contact The Gross Law Firm Before March 31, 2025 to Discuss Your Rights - WBA",
    "date": "2025-02-10 16:15:00",
    "journal": "Dow Jones Institutional News",
    "company": "N/A",
    "region": "namz : North America | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.809358179569244,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 11,
    "sentence": "id=127859&amp;from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or <span class=\"highlight-negative\">misleading</span> statements and/or failed to disclose that: (i) contrary to the Company&#x27;s purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens&#x27; revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company&#x27;s public statements were materially false and <span class=\"highlight-negative\">misleading</span> at all relevant times.",
    "sentenceRaw": "id=127859&from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) contrary to the Company's purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens' revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 38796,
    "title": "Press Release WBA Investor News Rosen Law Firm Encourages Walgreens Boots Alliance , Inc. Investors to Inquire About Securities Class Action Investigation - WBA",
    "date": "2025-02-03 23:21:00",
    "journal": "Dow Jones Institutional News",
    "company": "N/A",
    "region": "namz : North America | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.911946296691895,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 2,
    "sentence": "(NASDAQ: WBA) resulting from allegations that Walgreens may have issued materially <span class=\"highlight-negative\">misleading</span> business information to the investing public.",
    "sentenceRaw": "(NASDAQ: WBA) resulting from allegations that Walgreens may have issued materially misleading business information to the investing public.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 38894,
    "title": "Press Release Contact The Gross Law Firm by March 31, 2025 Deadline to Join Class Action Against Walgreens Boots Alliance , Inc.(WBA)",
    "date": "2025-02-27 16:15:00",
    "journal": "Dow Jones Institutional News",
    "company": "N/A",
    "region": "namz : North America | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.808873653411865,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 11,
    "sentence": "id=132342&amp;from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or <span class=\"highlight-negative\">misleading</span> statements and/or failed to disclose that: (i) contrary to the Company&#x27;s purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens&#x27; revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company&#x27;s public statements were materially false and <span class=\"highlight-negative\">misleading</span> at all relevant times.",
    "sentenceRaw": "id=132342&from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) contrary to the Company's purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens' revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 38895,
    "title": "Press Release Contact The Gross Law Firm by March 31, 2025 Deadline to Join Class Action Against Walgreens Boots Alliance , Inc.(WBA)",
    "date": "2025-02-27 16:15:00",
    "journal": "Dow Jones Institutional News",
    "company": "N/A",
    "region": "namz : North America | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.808873653411865,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 11,
    "sentence": "id=132342&amp;from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or <span class=\"highlight-negative\">misleading</span> statements and/or failed to disclose that: (i) contrary to the Company&#x27;s purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens&#x27; revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company&#x27;s public statements were materially false and <span class=\"highlight-negative\">misleading</span> at all relevant times.",
    "sentenceRaw": "id=132342&from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) contrary to the Company's purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens' revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 38987,
    "title": "Press Release Shareholders that lost money on Walgreens Boots Alliance , Inc.(WBA) should contact The Gross Law Firm about pending Class Action - WBA",
    "date": "2025-03-06 16:15:00",
    "journal": "Dow Jones Institutional News",
    "company": "N/A",
    "region": "namz : North America | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.807308733463287,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 11,
    "sentence": "id=134045&amp;from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or <span class=\"highlight-negative\">misleading</span> statements and/or failed to disclose that: (i) contrary to the Company&#x27;s purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens&#x27; revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company&#x27;s public statements were materially false and <span class=\"highlight-negative\">misleading</span> at all relevant times.",
    "sentenceRaw": "id=134045&from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) contrary to the Company's purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens' revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 38988,
    "title": "Press Release Shareholders that lost money on Walgreens Boots Alliance , Inc.(WBA) should contact The Gross Law Firm about pending Class Action - WBA",
    "date": "2025-03-06 16:15:00",
    "journal": "Dow Jones Institutional News",
    "company": "N/A",
    "region": "namz : North America | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.807308733463287,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 11,
    "sentence": "id=134045&amp;from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or <span class=\"highlight-negative\">misleading</span> statements and/or failed to disclose that: (i) contrary to the Company&#x27;s purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens&#x27; revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company&#x27;s public statements were materially false and <span class=\"highlight-negative\">misleading</span> at all relevant times.",
    "sentenceRaw": "id=134045&from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) contrary to the Company's purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens' revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 39065,
    "title": "Press Release The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 31, 2025 in Walgreens Boots Alliance , Inc. Lawsuit - WBA",
    "date": "2025-02-20 16:15:00",
    "journal": "Dow Jones Institutional News",
    "company": "N/A",
    "region": "namz : North America | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.808452188968658,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 11,
    "sentence": "id=130535&amp;from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or <span class=\"highlight-negative\">misleading</span> statements and/or failed to disclose that: (i) contrary to the Company&#x27;s purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens&#x27; revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company&#x27;s public statements were materially false and <span class=\"highlight-negative\">misleading</span> at all relevant times.",
    "sentenceRaw": "id=130535&from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) contrary to the Company's purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens' revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 39066,
    "title": "Press Release The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 31, 2025 in Walgreens Boots Alliance , Inc. Lawsuit - WBA",
    "date": "2025-02-20 16:15:00",
    "journal": "Dow Jones Institutional News",
    "company": "N/A",
    "region": "namz : North America | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.808452188968658,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 11,
    "sentence": "id=130535&amp;from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or <span class=\"highlight-negative\">misleading</span> statements and/or failed to disclose that: (i) contrary to the Company&#x27;s purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens&#x27; revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company&#x27;s public statements were materially false and <span class=\"highlight-negative\">misleading</span> at all relevant times.",
    "sentenceRaw": "id=130535&from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) contrary to the Company's purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens' revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 39089,
    "title": "Press Release Contact The Gross Law Firm by March 31, 2025 Deadline to Join Class Action Against Walgreens Boots Alliance , Inc.(WBA)",
    "date": "2025-02-24 16:15:00",
    "journal": "Dow Jones Institutional News",
    "company": "N/A",
    "region": "namz : North America | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.808883905410767,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 11,
    "sentence": "id=131205&amp;from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or <span class=\"highlight-negative\">misleading</span> statements and/or failed to disclose that: (i) contrary to the Company&#x27;s purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens&#x27; revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company&#x27;s public statements were materially false and <span class=\"highlight-negative\">misleading</span> at all relevant times.",
    "sentenceRaw": "id=131205&from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) contrary to the Company's purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens' revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 39090,
    "title": "Press Release Contact The Gross Law Firm by March 31, 2025 Deadline to Join Class Action Against Walgreens Boots Alliance , Inc.(WBA)",
    "date": "2025-02-24 16:15:00",
    "journal": "Dow Jones Institutional News",
    "company": "N/A",
    "region": "namz : North America | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.808883905410767,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 11,
    "sentence": "id=131205&amp;from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or <span class=\"highlight-negative\">misleading</span> statements and/or failed to disclose that: (i) contrary to the Company&#x27;s purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens&#x27; revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company&#x27;s public statements were materially false and <span class=\"highlight-negative\">misleading</span> at all relevant times.",
    "sentenceRaw": "id=131205&from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) contrary to the Company's purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens' revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 39528,
    "title": "Press Release Contact The Gross Law Firm by March 31, 2025 Deadline to Join Class Action Against Walgreens Boots Alliance , Inc.(WBA)",
    "date": "2025-03-13 15:15:00",
    "journal": "Dow Jones Institutional News",
    "company": "N/A",
    "region": "namz : North America | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.808216691017151,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 11,
    "sentence": "id=135477&amp;from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or <span class=\"highlight-negative\">misleading</span> statements and/or failed to disclose that: (i) contrary to the Company&#x27;s purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens&#x27; revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company&#x27;s public statements were materially false and <span class=\"highlight-negative\">misleading</span> at all relevant times.",
    "sentenceRaw": "id=135477&from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) contrary to the Company's purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens' revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 39529,
    "title": "Press Release Contact The Gross Law Firm by March 31, 2025 Deadline to Join Class Action Against Walgreens Boots Alliance , Inc.(WBA)",
    "date": "2025-03-13 15:15:00",
    "journal": "Dow Jones Institutional News",
    "company": "N/A",
    "region": "namz : North America | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.808216691017151,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 11,
    "sentence": "id=135477&amp;from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or <span class=\"highlight-negative\">misleading</span> statements and/or failed to disclose that: (i) contrary to the Company&#x27;s purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens&#x27; revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company&#x27;s public statements were materially false and <span class=\"highlight-negative\">misleading</span> at all relevant times.",
    "sentenceRaw": "id=135477&from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) contrary to the Company's purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens' revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 39544,
    "title": "Press Release Shareholders that lost money on Walgreens Boots Alliance , Inc.(WBA) should contact The Gross Law Firm about pending Class Action - WBA",
    "date": "2025-03-17 15:15:00",
    "journal": "Dow Jones Institutional News",
    "company": "N/A",
    "region": "namz : North America | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.807532012462616,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 11,
    "sentence": "id=136007&amp;from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or <span class=\"highlight-negative\">misleading</span> statements and/or failed to disclose that: (i) contrary to the Company&#x27;s purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens&#x27; revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company&#x27;s public statements were materially false and <span class=\"highlight-negative\">misleading</span> at all relevant times.",
    "sentenceRaw": "id=136007&from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) contrary to the Company's purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens' revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 39545,
    "title": "Press Release Shareholders that lost money on Walgreens Boots Alliance , Inc.(WBA) should contact The Gross Law Firm about pending Class Action - WBA",
    "date": "2025-03-17 15:15:00",
    "journal": "Dow Jones Institutional News",
    "company": "N/A",
    "region": "namz : North America | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.807532012462616,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 11,
    "sentence": "id=136007&amp;from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or <span class=\"highlight-negative\">misleading</span> statements and/or failed to disclose that: (i) contrary to the Company&#x27;s purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens&#x27; revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company&#x27;s public statements were materially false and <span class=\"highlight-negative\">misleading</span> at all relevant times.",
    "sentenceRaw": "id=136007&from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) contrary to the Company's purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens' revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 39685,
    "title": "Press Release The Gross Law Firm Notifies Shareholders of Walgreens Boots Alliance , Inc.(WBA) of a Class Action Lawsuit and an Upcoming Deadline",
    "date": "2025-03-20 14:34:00",
    "journal": "Dow Jones Institutional News",
    "company": "N/A",
    "region": "namz : North America | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.798254370689392,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 11,
    "sentence": "id=137069&amp;from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or <span class=\"highlight-negative\">misleading</span> statements and/or failed to disclose that: (i) contrary to the Company&#x27;s purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens&#x27; revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company&#x27;s public statements were materially false and <span class=\"highlight-negative\">misleading</span> at all relevant times.",
    "sentenceRaw": "id=137069&from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) contrary to the Company's purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens' revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  },
  {
    "id": 39686,
    "title": "Press Release The Gross Law Firm Notifies Shareholders of Walgreens Boots Alliance , Inc.(WBA) of a Class Action Lawsuit and an Upcoming Deadline",
    "date": "2025-03-20 14:34:00",
    "journal": "Dow Jones Institutional News",
    "company": "N/A",
    "region": "namz : North America | usa : United States",
    "sentiment": "negative",
    "sentimentScore": 0.798254370689392,
    "matchedText": "misleading",
    "matchType": "word",
    "numMatches": 11,
    "sentence": "id=137069&amp;from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or <span class=\"highlight-negative\">misleading</span> statements and/or failed to disclose that: (i) contrary to the Company&#x27;s purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens&#x27; revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company&#x27;s public statements were materially false and <span class=\"highlight-negative\">misleading</span> at all relevant times.",
    "sentenceRaw": "id=137069&from=4 CLASS PERIOD: April 2, 2020 to January 16, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) contrary to the Company's purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens' revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.",
    "attitudeType": "judgement",
    "attitudeSubtype": "tenacity",
    "attitudePolarity": "negative"
  }
]